GlassScriptPhysician profile
Naim Salloum
NPI 1205870656
$2,045.87
in general payments reported to CMS, 2019-2025
16 companies · $499 in 2025
The $499 reported for 2025 was more than what 75% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $23.13 · 2021: $44.42 · 2022: $481 · 2023: $305 · 2024: $493 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017 · Education: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.01 |
| Education | $278.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $395.66 | 2019-2025 | |
| Janssen Biotech, INC. | $365.57 | 2022-2025 | Erleada, Balversa, Akeega |
| Astellas Pharma US INC | $316.35 | 2019-2025 | Xtandi |
| Myriad Genetic Laboratories, INC. | $315.01 | 2022-2023 | Prolaris |
| Novartis Pharmaceuticals Corporation | $210.69 | 2022-2025 | |
| Boston Scientific Corporation | $89.47 | 2019 | |
| Pfizer INC. | $71.84 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $59.00 | 2025 | Orgovyx |
| Progenics Pharmaceuticals, INC. | $48.30 | 2022-2025 | |
| Siemens Medical Solutions USA, INC. | $34.71 | 2022-2024 | Magnetom Sola |
| Hologic Sales and Service, LLC | $28.34 | 2023 | Biozorb |
| Novocure INC. | $28.22 | 2025 | Optune Gio |
| Ge Healthcare | $26.81 | 2021 | |
| Teleflex LLC | $19.90 | 2024 | |
| Blue Earth Diagnostics | $18.39 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viewray Technologies INC | $17.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naim Salloum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.